Lucia Novoa-Fernandez
Bergondo, GA 15165, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 22, 2021
Atremorine in Parkinson's disease: From dopaminergic neuroprotection to pharmacogenomics.
Journal: Medicinal research reviews
Published: May 28, 2020
DNA Methylation in Neurodegenerative and Cerebrovascular Disorders.
Journal: International journal of molecular sciences
Published: February 17, 2020
Nutrition, Health, and Disease: Role of Selected Marine and Vegetal Nutraceuticals.
Journal: Nutrients
Published: January 13, 2020
Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson's Disease.
Pharmacogenetics of Atremorine-Induced Neuroprotection and Dopamine Response in Parkinson's Disease.
Journal: Planta medica
Published: September 28, 2019
Neuroprotective Effect of Atremorine in an Experimental Model of Parkinson's Disease.
Journal: Current pharmaceutical design
Published: August 02, 2016
E-MHK-0103 (Mineraxin™): A Novel Nutraceutical with Biological Properties in Menopausal Conditions.
Journal: Current drug metabolism
Published: June 22, 2016
Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease.
Journal: Current medicinal chemistry
Published: April 11, 2016
Histamine and Immune Biomarkers in CNS Disorders.
Journal: Mediators of inflammation
Published: November 19, 2015
Validating Immunotherapy in Alzheimer's Disease: The EB101 Vaccine.
Journal: Current pharmaceutical design
Published: October 26, 2015
Neuroimmune Crosstalk in CNS Disorders: The Histamine Connection.
Journal: Current pharmaceutical design
Published: October 26, 2015
Novel Therapeutic Strategies for Dementia.
Journal: CNS & neurological disorders drug targets
Published: September 11, 2015
Last Updated: 09/26/2026